By: Ronald W. Chapman II
The U.S. Sentencing Commission has published its proposed amendments to the federal sentencing guidelines for 2025. These changes address significant areas of supervised release, drug offenses, and revocation policies.
One of the most notable changes proposed in the amendments is the increased discretion given to courts in determining supervised release terms. Under the new framework, judges will no longer be required to impose a term of supervised release simply because a defendant has received a sentence exceeding one year of imprisonment. Instead, the decision to impose supervised release must be based on an individualized assessment of whether supervision is necessary for rehabilitation and public safety.
Courts will only be required to impose supervised release when mandated by statute.
Judges must justify their reasoning on the record when imposing or declining to impose supervised release.
The guidelines no longer recommend a presumptive term of supervised release for sex offenses, replacing it with a requirement that courts assess the need for lifetime supervision on a case-by-case basis.
Conditions of supervised release will also be determined through individualized assessments, replacing the prior “standard” conditions with a list of suggested conditions.
The proposed amendments continue the Commission’s efforts to address sentencing disparities in drug-related offenses. Specifically, the changes aim to:
Reduce disparities in sentencing for drug offenders who qualify under the “safety valve” provision, allowing more defendants to avoid mandatory minimum sentences.
Revise the treatment of recidivist drug offenders, ensuring that prior convictions used to enhance sentences are more narrowly defined.
Allow greater sentencing leniency for defendants who provide substantial assistance to law enforcement in drug-related cases.
These changes align with legislative efforts to address the impact of harsh sentencing on low-level drug offenders and could significantly affect plea negotiations for defendants facing controlled substance charges.
The proposed amendments introduce a major restructuring of the guidelines governing revocation of supervised release. The revisions aim to provide courts with greater flexibility when responding to violations, recognizing that not all violations warrant revocation and imprisonment.
Creation of a new “Grade D” violation category for technical violations, allowing courts to respond with alternatives to incarceration.
Courts are encouraged to consider alternatives to revocation, such as modifying conditions of supervised release, extending supervision, or imposing graduated sanctions.
The guidelines eliminate the mandatory recommendation that supervised release terms run consecutively to any new sentence, allowing courts to determine whether a concurrent sentence is appropriate.
Encouragement for courts to consider early termination of supervised release after one year if the defendant demonstrates compliance and low risk.
The increased judicial discretion in supervised release decisions means that defense attorneys must be prepared to advocate more persuasively for their clients. Attorneys should:
Prepare compelling arguments regarding why supervised release may not be necessary in a particular case.
Argue for shorter supervised release terms where applicable.
Highlight a defendant’s rehabilitation efforts when advocating for early termination.
Take advantage of the expanded eligibility for safety valve relief in drug cases.
Ronald Chapman II is the founder of Chapman, Dowling & Mallek and a top-rated Michigan federal criminal defense attorney who represents clients in federal courts nationwide. His practice is focused on defending individuals and organizations in complex federal prosecutions, including white-collar criminal matters and healthcare fraud investigations.
Throughout his career, Mr. Chapman has helped clients avoid more than $550 million in potential penalties, primarily in cases involving physicians, healthcare providers, executives, and professionals facing federal charges. He is widely recognized for his work as a Michigan healthcare fraud defense attorney, as well as for his results in white collar criminal defense in Michigan, where cases often involve parallel civil, regulatory, and criminal exposure.
Apr-8-2026
Hospice fraud is a serious enforcement priority for Medicare, and federal regulators are under pressure...
Apr-2-2026
In federal court, some of the most important battles happen after trial—on appeal—where the focus...
Jan-9-2026
Memphis, Tennessee – The verdict returned this week in United States v. Sanjeev Kumar closed...
Dec-31-2025
Dr. Lonnie Joseph Parker, a Texarkana physician, was recently convicted in federal court of unlawfully...
Serving Clients Nationwide.
Chapman, Dowling & Mallek is headquartered in Detroit, Michigan and represents clients in federal investigations and criminal matters across the United States. Our attorneys handle complex federal cases nationwide while maintaining offices in Michigan and other states.
456 E. Milwaukee, Detroit, MI 48202
One Comment
Truly believe they should change the purity law with methamphetamine. People are doing decades for literally a gram or 2 . The feds isn't for petit drug addicts, it's for cartels and big drug dealers and terrorists and child predators. It must go retroactive, there are kids who made a mistake or two that will never see their family again for a couple grams of a drug that is so cheap and abundant in this country. Go after the cartels and big dealers and help the people from poor familys and towns with their addiction. Not everyone in prison are bad people. Imagine yourself in a cell for literally 20 years or more. I couldn't imagine it. So sad . Praying for Justice